|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/88 | (2006.01) |
| C12N 9/88 | (2013.01) | ||
| A61K 38/51 | (2006.01) | ||
| C12Y 402/01022 | (2013.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/205 | (2013.01) | ||
| A61K 31/205 | (2006.01) | ||
| A61K 31/385 | (2006.01) | ||
| A61K 31/385 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 47/60 | (2017.08) | ||
| A61P 9/10 | (2006.01) | ||
| C12N 9/96 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 38/51 | (2013.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| C12N 9/96 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3712264 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20168207.7 |
| Date of filing the European patent application | 2014-01-29 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361758138 P | 2013-01-29 | US | |
| 201313803804 | 2013-03-14 | US |
| (72) |
KRAUS, Jan P. , US
MAJTAN, Tomas , US
BUBLIL, Erez , IL
|
| (73) |
The Regents of the University of Colorado,
A Body Corporate ,
1800 Grant Street, 8th Floor, Denver, CO 80203,
US
|
| (54) | CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA |
| CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA |